SpringWorks Therapeutics (SWTX) Short Interest Ratio & Short Volume $46.27 +0.06 (+0.13%) Closing price 04:00 PM EasternExtended Trading$46.28 +0.01 (+0.02%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SpringWorks Therapeutics Short Interest DataSpringWorks Therapeutics (SWTX) has a short interest of 5.27 million shares. This marks a -33.46% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 2.15 million shares to cover all short positions.Current Short Interest5,270,000 sharesPrevious Short Interest7,920,000 sharesChange Vs. Previous Month-33.46%Dollar Volume Sold Short$244.00 millionShort Interest Ratio1.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares75,323,000 sharesPercentage of Shares Shorted7.00%Today's Trading Volume3,033,755 sharesAverage Trading Volume2,147,305 sharesToday's Volume Vs. Average141% Short Selling SpringWorks Therapeutics? Sign up to receive the latest short interest report for SpringWorks Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSWTX Short Interest Over TimeSWTX Days to Cover Over TimeSWTX Percentage of Float Shorted Over Time SpringWorks Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20255,270,000 shares $244.00 million -33.5%N/A1.1 $46.30 4/15/20257,920,000 shares $297.71 million -4.4%11.5%2.9 $37.59 3/31/20258,280,000 shares $365.40 million +10.0%12.0%3.2 $44.13 3/15/20257,530,000 shares $385.08 million +5.9%11.0%3.3 $51.14 2/28/20257,110,000 shares $410.67 million -22.0%10.3%3.2 $57.76 2/15/20259,110,000 shares $523.19 million -36.7%13.3%4.6 $57.43 1/31/202514,400,000 shares $540 million +5.4%N/A8 $37.50 1/15/202513,660,000 shares $457.34 million +11.3%N/A10.3 $33.48 12/31/202412,270,000 shares $443.32 million +5.0%N/A10.2 $36.13 12/15/202411,690,000 shares $447.73 million -1.5%N/A10.4 $38.30 Get the Latest News and Ratings for SWTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SpringWorks Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/202411,870,000 shares $492.37 million -3.4%N/A10.9 $41.48 11/15/202412,290,000 shares $447.97 million +5.7%N/A11.3 $36.45 10/31/202411,630,000 shares $350.41 million -8.9%N/A13.3 $30.13 10/15/202412,770,000 shares $389.49 million +4.8%N/A13.8 $30.50 9/30/202412,180,000 shares $390.25 million -11.1%N/A13.2 $32.04 9/15/202413,700,000 shares $512.65 million +7.7%N/A15.4 $37.42 8/31/202412,720,000 shares $530.55 million -4.4%N/A15.2 $41.71 8/15/202413,300,000 shares $481.59 million +16.8%N/A16 $36.21 7/31/202411,390,000 shares $409.01 million +7.9%N/A13.9 $35.91 7/15/202410,560,000 shares $441.83 million +1.3%N/A12.9 $41.84 6/30/202410,420,000 shares $392.52 million -7.3%N/A13.2 $37.67 6/15/202411,240,000 shares $433.30 million +4.1%N/A13.9 $38.55 5/31/202410,800,000 shares $447.77 million +1.0%N/A12.8 $41.46 5/15/202410,690,000 shares $483.19 million +6.8%N/A11.5 $45.20 4/30/202410,010,000 shares $467.37 million -5.0%N/A8.8 $46.69 4/15/202410,540,000 shares $448.06 million -1.1%N/A9.5 $42.51 3/31/202410,660,000 shares $524.69 million -4.6%N/A9.3 $49.22 3/15/202411,170,000 shares $561.63 million +0.4%N/A9.3 $50.28 2/29/202411,130,000 shares $548.26 million -2.5%N/A8.5 $49.26 2/15/202411,410,000 shares $548.02 million +9.6%N/A7.6 $48.03 1/31/202410,410,000 shares $459.39 million No ChangeN/A7.7 $44.13 1/15/202410,410,000 shares $426.08 million -7.1%N/A8.3 $40.93 12/31/202311,210,000 shares $409.17 million +2.0%N/A9.2 $36.50 12/15/202310,990,000 shares $373.55 million +7.9%N/A9.8 $33.99 11/30/202310,190,000 shares $309.67 million +3.2%N/A10.2 $30.39 11/15/20239,870,000 shares $217.83 million -3.3%20.4%16.4 $22.07 10/31/202310,210,000 shares $233.81 million -1.7%21.2%17.7 $22.90 10/15/202310,390,000 shares $235.75 million -27.0%21.6%19.7 $22.69 9/30/202314,230,000 shares $329.00 million -2.4%29.5%27.6 $23.12 9/15/202314,580,000 shares $384.04 million +0.3%30.2%28.4 $26.34AI Meltdown Imminent: Dump These Stocks Now! (Ad)If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.Click here to see the details and learn how to prepare for the next AI revolution 8/31/202314,530,000 shares $409.46 million -3.7%N/A24.7 $28.18 8/15/202315,090,000 shares $439.72 million +0.1%N/A24 $29.14 7/31/202315,080,000 shares $473.21 million +1.0%N/A24 $31.38 7/15/202314,930,000 shares $427.00 million -0.1%31.5%23.1 $28.60 6/30/202314,940,000 shares $391.73 million +8.9%31.5%22.3 $26.22 6/15/202313,720,000 shares $384.98 million +11.0%28.9%19.8 $28.06 5/31/202312,360,000 shares $338.42 million +3.1%26.1%17.9 $27.38 5/15/202311,990,000 shares $368.45 million +3.7%25.3%17.1 $30.73 4/30/202311,560,000 shares $270.27 million +3.4%24.7%17.2 $23.38 4/15/202311,180,000 shares $267.54 million -4.1%23.9%16.3 $23.93 3/31/202311,660,000 shares $300.13 million -5.7%25.2%16.7 $25.74 3/15/202312,370,000 shares $391.02 million +6.5%26.8%16.8 $31.61 2/28/202311,620,000 shares $370.68 million +1.7%26.1%16.2 $31.90 2/15/202311,430,000 shares $348.27 million -6.7%25.7%16.5 $30.47 1/31/202312,250,000 shares $384.65 million -1.8%29.7%16.5 $31.40 1/15/202312,480,000 shares $362.04 million +9.1%28.0%16.5 $29.01 12/30/202211,440,000 shares $297.55 million +10.3%25.6%15.1 $26.01 12/15/202210,370,000 shares $234.05 million -10.7%23.5%13.8 $22.57 11/30/202211,610,000 shares $280.73 million -4.1%26.3%14.6 $24.18 11/15/202212,100,000 shares $331.54 million +9.5%27.4%14.5 $27.40 10/31/202211,050,000 shares $265.31 million +7.6%25.1%12 $24.01 10/15/202210,270,000 shares $258.80 million +4.4%23.3%11.4 $25.20 9/30/20229,840,000 shares $280.74 million +16.5%22.6%11 $28.53 9/15/20228,450,000 shares $257.05 million -5.1%24.5%9 $30.42 8/31/20228,900,000 shares $247.15 million -4.2%23.3%8.9 $27.77 8/15/20229,290,000 shares $283.53 million -24.2%28.8%6.7 $30.52 7/31/202212,260,000 shares $366.33 million +3.3%38.8%9.4 $29.88 7/15/202211,870,000 shares $350.64 million +3.9%37.5%9.4 $29.54 6/30/202211,430,000 shares $281.41 million +7.3%36.1%9.2 $24.62 6/15/202210,650,000 shares $223.33 million +43.2%33.6%9 $20.97 5/31/20227,440,000 shares $140.91 million +21.8%23.5%7.5 $18.94 5/15/20226,110,000 shares $239.45 million +5.2%19.2%10.8 $39.19 4/30/20225,810,000 shares $249.31 million +17.6%18.3%13.1 $42.91 4/15/20224,940,000 shares $264.64 million +15.2%15.6%11.8 $53.57 3/31/20224,290,000 shares $242.13 million +10.6%13.6%9.7 $56.44 3/15/20223,880,000 shares $206.45 million +2.7%12.3%9.3 $53.21 2/28/20223,780,000 shares $213.91 million -1.6%11.9%9.1 $56.59 2/15/20223,840,000 shares $225.75 million +11.3%12.2%9.5 $58.79 1/31/20223,450,000 shares $192.10 million +23.7%11.8%8.7 $55.68 1/15/20222,790,000 shares $174.32 million +6.1%8.9%7.3 $62.48 12/31/20212,630,000 shares $163.01 million -9.0%8.3%7.9 $61.98 12/15/20212,890,000 shares $205.51 million -2.7%9.1%8.6 $71.11 11/30/20212,970,000 shares $213.39 million -12.7%9.4%9.1 $71.85 11/15/20213,400,000 shares $236.74 million -15.2%10.7%11.1 $69.63 10/29/20214,010,000 shares $268.91 million +7.8%12.7%13.2 $67.06 10/15/20213,720,000 shares $227.37 million +13.8%11.8%12.9 $61.12 9/30/20213,270,000 shares $207.45 million +4.5%10.4%12.3 $63.44 9/15/20213,130,000 shares $225.77 million -4.3%9.9%12.5 $72.13 8/31/20213,270,000 shares $245.58 million +3.8%10.4%13.8 $75.10 8/13/20213,150,000 shares $237.23 million -5.1%10.0%13.3 $75.31Trump Predicts Dollar Downfall (Ad)READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now. 7/30/20213,320,000 shares $284.52 million -1.8%10.9%14.7 $85.70 7/15/20213,380,000 shares $263.67 million -2.6%9.3%15 $78.01 6/30/20213,470,000 shares $285.96 million -1.4%9.5%15.1 $82.41 6/15/20213,520,000 shares $280.47 million -7.4%9.7%14.2 $79.68 5/28/20213,800,000 shares $309.85 million +0.3%10.4%13.8 $81.54 5/14/20213,790,000 shares $258.93 million -4.1%10.4%11.5 $68.32 4/30/20213,950,000 shares $289.46 million -3.0%10.9%11.4 $73.28 4/15/20214,070,000 shares $295.89 million +8.5%11.2%11.6 $72.70 3/31/20213,750,000 shares $256.80 million +9.7%10.6%9.9 $68.48 3/15/20213,420,000 shares $268.47 million +4.0%9.7%8.8 $78.50 2/26/20213,290,000 shares $292.81 million +8.2%9.7%9.5 $89.00 2/12/20213,040,000 shares $272.96 million -2.6%9.0%9.7 $89.79 1/29/20213,120,000 shares $251.41 million -10.3%9.3%9.2 $80.58 1/15/20213,480,000 shares $259.75 million -1.1%10.3%10.2 $74.64 12/31/20203,520,000 shares $255.13 million +18.9%10.4%10.6 $72.48 12/15/20202,960,000 shares $221.64 million -5.4%8.7%8.2 $74.88 11/30/20203,130,000 shares $212.84 million +2.6%9.2%8.5 $68.00 11/15/20203,050,000 shares $205.84 million +1.7%9.0%8.8 $67.49 10/30/20203,000,000 shares $178.44 million +6.4%9.0%9.2 $59.48 10/15/20202,820,000 shares $162.60 million -10.5%9.0%9.7 $57.66 9/30/20203,150,000 shares $150.16 million +37.0%10.1%11.4 $47.67 9/15/20202,300,000 shares $99.73 million +0.9%8.2%9.4 $43.36 8/31/20202,280,000 shares $101.25 million +5.1%8.1%10.7 $44.41 8/14/20202,170,000 shares $89.06 million +3.3%7.7%10.3 $41.04 7/31/20202,100,000 shares $89.52 million +1.5%7.5%10.1 $42.63 7/15/20202,070,000 shares $77.07 million -2.8%7.4%10.2 $37.23 6/30/20202,130,000 shares $89.46 million +24.6%7.6%11.2 $42.00 6/15/20201,710,000 shares $73.46 million +3.6%6.1%11.1 $42.96 5/29/20201,650,000 shares $60.80 million -9.3%5.9%11 $36.85 SWTX Short Interest - Frequently Asked Questions What is SpringWorks Therapeutics' current short interest? Short interest is the volume of SpringWorks Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 5,270,000 shares of SWTX short. Learn More on SpringWorks Therapeutics' current short interest. What is a good short interest ratio for SpringWorks Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SWTX shares currently have a short interest ratio of 1.0. Learn More on SpringWorks Therapeutics's short interest ratio. Which institutional investors are shorting SpringWorks Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of SpringWorks Therapeutics: Jane Street Group LLC, Twin Securities Inc., Caption Management LLC, Eisler Capital Management Ltd., Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Maven Securities LTD, Summit Securities Group LLC, Simplex Trading LLC, and Covestor Ltd. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is SpringWorks Therapeutics' short interest increasing or decreasing? SpringWorks Therapeutics saw a drop in short interest in April. As of April 30th, there was short interest totaling 5,270,000 shares, a drop of 33.5% from the previous total of 7,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does SpringWorks Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to SpringWorks Therapeutics: Genmab A/S (0.39%), Dr. Reddy's Laboratories Limited (1.79%), Viatris Inc. (4.27%), Moderna, Inc. (17.58%), Qiagen (2.35%), Ascendis Pharma A/S (6.40%), Roivant Sciences Ltd. (12.03%), Revolution Medicines, Inc. (8.89%), BridgeBio Pharma, Inc. (11.68%), Blueprint Medicines Co. (8.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short SpringWorks Therapeutics stock? Short selling SWTX is an investing strategy that aims to generate trading profit from SpringWorks Therapeutics as its price is falling. SWTX shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SpringWorks Therapeutics? A short squeeze for SpringWorks Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SWTX, which in turn drives the price of the stock up even further. How often is SpringWorks Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SWTX, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Genmab A/S Short Squeeze Dr. Reddy's Laboratories Short Squeeze Viatris Short Squeeze Moderna Short Squeeze Qiagen Short Squeeze Ascendis Pharma A/S Short Squeeze Roivant Sciences Short Squeeze Revolution Medicines Short Squeeze BridgeBio Pharma Short Squeeze Blueprint Medicines Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SWTX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
